KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Equity Ratio: 2009-2025

Historic Equity Ratio for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to 0.45.

  • Quest Diagnostics' Equity Ratio rose 5.96% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year increase of 5.96%. This contributed to the annual value of 0.42 for FY2024, which is 6.75% down from last year.
  • As of Q3 2025, Quest Diagnostics' Equity Ratio stood at 0.45, which was down 1.00% from 0.45 recorded in Q2 2025.
  • Quest Diagnostics' 5-year Equity Ratio high stood at 0.49 for Q1 2021, and its period low was 0.42 during Q4 2024.
  • Its 3-year average for Equity Ratio is 0.46, with a median of 0.45 in 2025.
  • Its Equity Ratio has fluctuated over the past 5 years, first dropped by 11.34% in 2024, then rose by 5.96% in 2025.
  • Quest Diagnostics' Equity Ratio (Quarterly) stood at 0.48 in 2021, then decreased by 3.01% to 0.46 in 2022, then decreased by 2.09% to 0.45 in 2023, then dropped by 6.75% to 0.42 in 2024, then increased by 5.96% to 0.45 in 2025.
  • Its Equity Ratio stands at 0.45 for Q3 2025, versus 0.45 for Q2 2025 and 0.44 for Q1 2025.